Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Sirolimus therapy in infants with severe hyperinsulinemic hypoglycemia.

Senniappan S, Alexandrescu S, Tatevian N, Shah P, Arya V, Flanagan S, Ellard S, Rampling D, Ashworth M, Brown RE, Hussain K.

N Engl J Med. 2014 Mar 20;370(12):1131-7. doi: 10.1056/NEJMoa1310967.

2.

Sirolimus in the treatment of three infants with diffuse congenital hyperinsulinism.

Al-Balwi R, Al-Atawi M, Al-Otaibi A, Babiker O, Al-Mutair A.

J Pediatr Endocrinol Metab. 2017 Aug 28;30(9):1013-1017. doi: 10.1515/jpem-2016-0229.

PMID:
28787272
3.

mTOR Inhibitors for the Treatment of Severe Congenital Hyperinsulinism: Perspectives on Limited Therapeutic Success.

Szymanowski M, Estebanez MS, Padidela R, Han B, Mosinska K, Stevens A, Damaj L, Pihan-Le Bars F, Lascouts E, Reynaud R, Ferreira C, Bansept C, de Lonlay P, Saint-Martin C, Dunne MJ, Banerjee I, Arnoux JB.

J Clin Endocrinol Metab. 2016 Dec;101(12):4719-4729. Epub 2016 Oct 3.

PMID:
27691052
4.

Sirolimus in severe hyperinsulinemic hypoglycemia.

Mao S, Zhang A, Huang S.

N Engl J Med. 2014 Jun 19;370(25):2448. doi: 10.1056/NEJMc1404716. No abstract available.

PMID:
24941188
5.

Sirolimus in severe hyperinsulinemic hypoglycemia.

Senniappan S, Brown RE, Hussain K.

N Engl J Med. 2014 Jun 19;370(25):2448-9. doi: 10.1056/NEJMc1404716. No abstract available.

6.

Efficacy and safety of sirolimus in a neonate with persistent hypoglycaemia following near-total pancreatectomy for hyperinsulinaemic hypoglycaemia.

Abraham MB, Shetty VB, Price G, Smith N, Bock Md, Siafarikas A, Resnick S, Whan E, Ellard S, Flanagan SE, Davis EA, Jones TW, Hussain K, Choong CS.

J Pediatr Endocrinol Metab. 2015 Nov 1;28(11-12):1391-8. doi: 10.1515/jpem-2015-0094.

PMID:
26226122
7.

Sirolimus therapy in a patient with severe hyperinsulinaemic hypoglycaemia due to a compound heterozygous ABCC8 gene mutation.

Shah P, Arya VB, Flanagan SE, Morgan K, Ellard S, Senniappan S, Hussain K.

J Pediatr Endocrinol Metab. 2015 May;28(5-6):695-9. doi: 10.1515/jpem-2014-0371.

PMID:
25518065
8.

A Novel Homozygous Mutation in the KCNJ11 Gene of a Neonate with Congenital Hyperinsulinism and Successful Management with Sirolimus.

Ünal S, Gönülal D, Uçaktürk A, Siyah Bilgin B, Flanagan SE, Gürbüz F, Tayfun M, Elmaoğulları S, Araslı A, Demirel F, Ellard S, Hussain K.

J Clin Res Pediatr Endocrinol. 2016 Dec 1;8(4):478-481. doi: 10.4274/jcrpe.2773. Epub 2016 May 16.

9.

Severe Hyperinsulinemic Hypoglycemia in a Neonate: Response to Sirolimus Therapy.

Méder Ü, Bokodi G, Balogh L, Körner A, Szabó M, Pruhova S, Szabó AJ.

Pediatrics. 2015 Nov;136(5):e1369-72. doi: 10.1542/peds.2014-4200.

10.

Experience of Octreotide Therapy for Hyperinsulinemic Hypoglycemia in Neonates Born Small for Gestational Age: A Case Series.

Pan S, Zhang M, Li Y.

Horm Res Paediatr. 2015;84(6):383-7. doi: 10.1159/000441108. Epub 2015 Oct 9.

11.

Hyperinsulinemic Hypoglycemia.

Güemes M, Hussain K.

Pediatr Clin North Am. 2015 Aug;62(4):1017-36. doi: 10.1016/j.pcl.2015.04.010. Epub 2015 May 13. Review.

PMID:
26210630
12.

Sirolimus Therapy in Congenital Hyperinsulinism: A Successful Experience Beyond Infancy.

Minute M, Patti G, Tornese G, Faleschini E, Zuiani C, Ventura A.

Pediatrics. 2015 Nov;136(5):e1373-6. doi: 10.1542/peds.2015-1132.

13.

Extreme caution on the use of sirolimus for the congenital hyperinsulinism in infancy patient.

Banerjee I, De Leon D, Dunne MJ.

Orphanet J Rare Dis. 2017 Apr 14;12(1):70. doi: 10.1186/s13023-017-0621-5.

14.

A combination of nifedipine and octreotide treatment in an hyperinsulinemic hypoglycemic infant.

Durmaz E, Flanagan SE, Parlak M, Ellard S, Akcurin S, Bircan I.

J Clin Res Pediatr Endocrinol. 2014;6(2):119-21. doi: 10.4274/Jcrpe.1230.

15.

An Egyptian case of congenital hyperinsulinism of infancy due to a novel mutation in KCNJ11 encoding Kir6.2 and response to octreotide.

Sherif EM, Abdelmaksoud AA, Elbarbary NS, Njølstad PR.

Acta Diabetol. 2013 Oct;50(5):801-5. doi: 10.1007/s00592-010-0217-1. Epub 2010 Aug 5.

PMID:
20686794
16.

Severe Hyperinsulinaemic Hypoglycaemia in Beckwith-Wiedemann Syndrome due to Paternal Uniparental Disomy of 11p15.5 Managed with Sirolimus Therapy.

Güemes M, Shah P, Roženková K, Gilbert C, Morgan K, Hussain K.

Horm Res Paediatr. 2016;85(5):353-7. doi: 10.1159/000443398. Epub 2016 Feb 11.

PMID:
26863215
17.

Nifedipine in Congenital Hyperinsulinism - A Case Report.

Khawash P, Hussain K, Flanagan SE, Chatterjee S, Basak D.

J Clin Res Pediatr Endocrinol. 2015 Jun;7(2):151-4. doi: 10.4274/jcrpe.1978.

18.

Persistent hyperinsulinemic hypoglycemia of infancy due to homozygous KCNJ11 (T294M) mutation.

Ilamaran V, Venkatesh C, Manish K, Adhisivam B.

Indian J Pediatr. 2010 Jul;77(7):803-4. doi: 10.1007/s12098-010-0100-7. Epub 2010 Jun 29.

PMID:
20589481
19.

Neonatal case of novel KMT2D mutation in Kabuki syndrome with severe hypoglycemia.

Gohda Y, Oka S, Matsunaga T, Watanabe S, Yoshiura K, Kondoh T, Matsumoto T.

Pediatr Int. 2015 Aug;57(4):726-8. doi: 10.1111/ped.12574. Epub 2015 May 5.

PMID:
25944076
20.

Treatment of hyperinsulinemic hypoglycemia because of diffuse nesidioblastosis with nifedipine after surgical therapies in a newborn.

Koklu E, Ozkan KU, Sayar H, Koklu S, Keskin M.

J Pediatr Endocrinol Metab. 2013;26(11-12):1153-6. doi: 10.1515/jpem-2013-0091.

PMID:
23751383

Supplemental Content

Support Center